GlassScriptPhysician profile
Madeline Eidson Buchanan
NPI 1255980439
$1,717.91
in general payments reported to CMS, 2019-2025
21 companies · $18.18 in 2025
The $18.18 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10.08 · 2022: $1,021 · 2023: $651 · 2024: $17.93 · 2025: $18.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $411.22 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $279.97 | 2022-2023 | Mounjaro, Trulicity, Jardiance |
| Abbvie INC. | $183.32 | 2022-2025 | |
| Glaxosmithkline, LLC. | $138.11 | 2022-2023 | Trelegy Ellipta, Boostrix, Shingrix |
| Merck Sharp & Dohme LLC | $113.54 | 2022-2023 | Belsomra, Steglujan, Steglatro |
| Biohaven Pharmaceutical Holding Company LTD. | $93.28 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $85.22 | 2022-2024 | Farxiga, Airsupra |
| Amarin Pharma, INC. | $73.89 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $51.77 | 2022-2023 | Quviviq |
| Amgen INC. | $49.60 | 2022-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.77 | 2022-2023 | Tradjenta |
| Takeda Pharmaceuticals U.S.A., INC. | $28.20 | 2022 | |
| Supernus Pharmaceuticals, INC. | $23.50 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $22.84 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $22.38 | 2023 | Xarelto |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $17.87 | 2023 | Trudhesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.74 | 2022 | |
| Exact Sciences Corporation | $17.71 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $16.69 | 2023 | |
| Eisai INC. | $12.21 | 2022 | |
| Genentech USA, INC. | $10.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.